SCHEMBL57998

SCHEMBL57998

O=C(O)N(c1ccccc1)c1cccc(Br)n1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.44
ALDH1A1 P00352 5/20 0.39
HPGD P15428 2/20 0.39
POLB P06746 2/20 0.38
KMT2A Q03164 2/20 0.38
NPC1 O15118 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
ATM Q13315 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
TSHR P16473 1/20 0.36
TRPM8 Q7Z2W7 1/20 0.35
GRM5 P41594 1/20 0.35
CLK1 P49759 1/20 0.33
MEN1 O00255 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
FAAH O00519 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL743478 0.81 NPSR1 (0.45) NPSR1ALDH1A1POLBKMT2ANPC1
SCHEMBL12987971 0.78 ALDH1A1 (0.39) ALDH1A1HPGDPOLBTDP1TSHR
SCHEMBL15228850 0.76 BACE1 (0.42) NPSR1ALDH1A1HPGDPOLBKMT2A
SCHEMBL10064916 0.76 ALDH1A1 (0.39) ALDH1A1HPGDPOLBKMT2ANPC1
SCHEMBL5907732 0.76 ALDH1A1 (0.39) ALDH1A1HPGDPOLBKMT2ANPC1
SCHEMBL743035 0.76 NPSR1 (0.40) NPSR1ALDH1A1POLBKMT2ANPC1
SCHEMBL60214 0.76 TAS2R14 (0.43) NPSR1ALDH1A1POLBKMT2ANPC1
SCHEMBL1400663 0.75 CLK1 (0.40) ALDH1A1HPGDPOLBKMT2ATDP1
SCHEMBL27854835 0.75 ALDH1A1 (0.37) ALDH1A1HPGDTDP1TSHRGRM5
SCHEMBL10855054 0.73 NPSR1 (0.50) NPSR1ALDH1A1HPGDPOLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143393-B2 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis BAYER HEALTHCARE LLC (US) 2012-03-27 US disclosed